You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 9, September 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Pediatric Neurology
 •Pediatrics, Other
 •Alert me on articles by topic

Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS)

Implications for Clinical Practice

Arch Pediatr Adolesc Med. 2004;158:927-929.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The term pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) identifies a subset of children with infection-related obsessive compulsive disorders (OCD) or tic disorders that meet the following 5 criteria: (1) presence of OCD and/or a tic disorder, (2) prepubertal symptom onset, (3) episodic course of symptom severity, (4) association with group A {beta}-hemolytic streptococcal (GAS) infection, and (5) association with neurological abnormalities.1 Although not without controversy,2 a mechanism similar to Sydenham chorea has been proposed for PANDAS, in which, in susceptible individuals, GAS infection triggers an antineuronal autoimmune response that negatively impacts striatal circuitry responsible for mediating OCD and tic symptoms.1 Thus, PANDAS by definition assumes that symptom onset or exacerbation is etiopathologically associated with GAS.3-4

Because an accurate diagnosis of PANDAS implies the need for acute and possibly prophylactic antibiotic treatment or perhaps more intensive immunomodulatory treatments, such as plasmapheresis, it is critical to accurately establish the . . . [Full Text of this Article]

John S. March, MD, MPH







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.